Barclays
YDES

Barclays’s YD Bio Ltd YDES Stock Holding History

Barclays’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58
Closed -$1.13K – 5841
2025
Q3 		$1.13K Buy
+58
New +$1.01K ﹤0.01% 5172

Other funds holding YDES

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barclays's YDES Position: Q4 2025 in Review

Barclays sold out of YD Bio Ltd (YDES) in Q4 2025, closing a stake of 58 shares — an estimated $1.13K sold.

Barclays first reported a position in YDES in Q3 2025 and held it in 1 quarter. The position peaked at $1.13K in Q3 2025. 10 funds tracked by Wall St. Rank hold YDES as of Q4 2025.

  • Barclays reported no remaining YD Bio Ltd position as of Q4 2025 after selling out during the quarter.
  • Barclays sold 58 YD Bio Ltd shares in Q4 2025, an estimated $1.13K.
  • Barclays first reported a position in YD Bio Ltd in Q3 2025 and held it in 1 quarter.
  • Barclays's YD Bio Ltd position peaked at $1.13K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held YD Bio Ltd as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.